Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer
Bengisu Dayanc(Izmir University), Şerif Şentürk(Izmir University)
Cited by 11
Related Papers
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization
|Nature Communications|2017|175
p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state
|Proceedings of the National Academy of Sciences|2014|94